- Home
- FG vs GRFS Comparison
FG vs GRFS Comparison
Compare FG & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- GRFS
- Stock Information
- Founded
- FG 1959
- GRFS 1940
- Country
- FG United States
- GRFS Spain
- Employees
- FG N/A
- GRFS N/A
- Industry
- FG Life Insurance
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- FG Finance
- GRFS Health Care
- Exchange
- FG Nasdaq
- GRFS Nasdaq
- Market Cap
- FG 5.3B
- GRFS 5.1B
- IPO Year
- FG N/A
- GRFS 2006
- Fundamental
- Price
- FG $36.05
- GRFS $7.11
- Analyst Decision
- FG Hold
- GRFS
- Analyst Count
- FG 3
- GRFS 0
- Target Price
- FG $46.67
- GRFS N/A
- AVG Volume (30 Days)
- FG 374.4K
- GRFS 1.1M
- Earning Date
- FG 05-07-2025
- GRFS 01-01-0001
- Dividend Yield
- FG 2.45%
- GRFS N/A
- EPS Growth
- FG N/A
- GRFS 283.33
- EPS
- FG 4.88
- GRFS 0.24
- Revenue
- FG $5,778,000,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- FG $4.52
- GRFS $8.45
- Revenue Next Year
- FG $7.47
- GRFS $7.08
- P/E Ratio
- FG $7.37
- GRFS $34.17
- Revenue Growth
- FG 27.35
- GRFS 9.41
- 52 Week Low
- FG $34.08
- GRFS $5.79
- 52 Week High
- FG $50.75
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- FG 37.89
- GRFS 34.78
- Support Level
- FG $34.08
- GRFS $7.13
- Resistance Level
- FG $36.50
- GRFS $7.81
- Average True Range (ATR)
- FG 1.31
- GRFS 0.23
- MACD
- FG -0.33
- GRFS -0.12
- Stochastic Oscillator
- FG 22.43
- GRFS 10.08
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)) and pension risk transfer (PRT) solutions.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.